Bovine herpesvirus type 4 (BHV-4) (Bartha et al., 1987) is one of the three bovine herpesviruses. BHV-1 and BHV-2 are responsible for infectious bovine rhinotracheitis/pustular vulvovaginitis and bovine herpes mammillitis, respectively (Ludwig, 1983) . BHV-4 has been isolated both from cattle showing various clinical symptoms (ocular, respiratory and genital involvements, skin lesions, malignant catarrhal fever or enteric diseases) and from healthy cattle (reviewed by Thiry et al., 1989) , and is distributed world-wide. In contrast to BHV-I and BHV-2, BHV-4 has so far not been established as the aetiological agent of a distinct disease entity but there is evidence of an association between BHV-4 infection and genital diseases in several countries (reviewed by .
BHV-4 has tentatively been classified as a cytomegalovirus based on its biological properties (Storz et al., 1984) but more recent data on the BHV-4 genome (Ehlers et al., 1985; Bublot et al., 1990) and the detection of a viral thymidine kinase (Kit et al., 1986) suggest that BHV-4 may be a member of the Gammaherpesvirinae group (Honess, 1984; Thiry et al., 1990; Staczeck, 1990) .
Twenty-nine BHV-4 structural proteins have already been identified by SDS-PAGE analysis of purified labelled virus, 10 of which are glycosylated. Three major glycoproteins were identified by anti-BHV-4 monoclonal antibodies (MAbs) (Dubuisson et al., 1989b; J. Dubuisson et al., unpublished results) . The first is a complex of three glycopolypeptides (gp6/gpl0/gpl7), the second, detected by Western blotting, is made up of one glycopolypeptide (gpl 1) linked to a 16.5K non-glycosylated polypeptide (VP24), and the third is a single glycopolypeptide (gp8). Moreover, a precursor has been identified for two components of the first glycoprotein [p(gpl0/gpl7)] (Dubuisson et al., 1989b) and another has 0001-0091 © 1991 SGM been suggested for the second glycoprotein (pgpll) .
Herpes simplex virus (HSV) proteins are expressed in a cascade. The first step occurs immediately after release of the virion genome from the capsid and produces the alpha proteins. The second step occurs after synthesis of alpha proteins and produces the beta proteins. The third step, producing the gamma proteins, is delayed until after the synthesis of virion DNA (Honess & Roizman, 1974 , 1975 . However, a subdivision has been defined for beta and gamma genes (Roizman & Sears, 1990) . Beta 1 polypeptides appear very early after infection and are differentiated from beta 2 polypeptides by their requirement for functional alpha 4 protein for their synthesis. The gamma 1 polypeptides are expressed relatively early in infection and they are only minimally affected by inhibitors of DNA synthesis. In contrast, gamma 2 polypeptides are expressed late in infection and are not expressed in the presence of effective concentrations of inhibitors of viral DNA synthesis. Gamma 1 genes have also been designated as beta-gamma genes (Sullivan et al., 1989; Roizman & Sears, 1990) .
Expression of BHV-4 proteins also appears to be temporally regulated (Metzler, 1990; V. Van Santen, personal communication) but the classification of each protein in the cascade has not yet been defined. This study was therefore undertaken in order to define the temporal appearance of BHV-4 glycoproteins.
To study the course of glycoprotein synthesis during the lytic cycle of virus replication, Madin Darby bovine kidney (MDBK) cells infected with plaque-purified BHV-4 strain V. Test (Thiry et al., 1981) post-inoculation (p.i.). At the end of each period, mock-infected and infected cells were disrupted with radioimmunoprecipitation assay (RIPA) buffer (0-15 MNaCI, 0-05 M-Tris-HC1 pH 7-2, I% Triton X-100, 0-1% SDS, 1% sodium deoxycholate, 0.1% NAN3). Cell lysates were cleared of cell debris by centrifugation for 15 min in an Eppendorf centrifuge and they were then immunoprecipitated with MAbs raised against BHV-4 glycoproteins (Dubuisson et al., 1989a, b; J. Dubuisson et al., unpublished results) or a rabbit polyclonal antiserum (harvested at day 41 p.i.) and analysed by SDS-PAGE as previously described (Dubuisson et al., 1989b) . This experiment showed that the three major BHV-4 glycoproteins were detected within the interval from 12 to 23 h until the end of experiment (76 h) when there was approximately 30% c.p.e. (Fig. 1) . The expression of gp6/gpl0/gpl7 and gpl 1/VP24 was still very high at the end of the experiment whereas the expression of glycoprotein gp8 seemed to decrease during the last interval (54 to 76 h).
In order to investigate the appearance of gp6/gpl0/gpl7, gpll/VP24 and gp8 glycoproteins, MDBK cells were infected with BHV-4 (m.o.i. > 10) and labelled at hourly intervals until 14 h p.i. as described by Ludwig & Letchworth (1987) . Briefly, cells were incubated in methionine-free MEM for 30 min, labelled with [3sS]methionine (100 p.Ci/ml; Amersham) for 1 h, and incubated with unlabelled methionine (5 mM) for 30 min. Cell lysates were harvested and analysed by RIPA using MAbs to the three BHV-4 glycoproteins and a polyclonal antiserum as described above. Results of this experiment were compared with those obtained by immunofluorescence. Briefly, MDBK cells grown in 96-well plates were infected with BHV-4 (m.o.i. > 1), fixed in acetone at -20 °C for 30 rain at hourly intervals until 14 h p.i. and glycoproteins were revealed with MAbs raised against BHV-4 glycoproteins as previously described (Dubuisson et al., 1989a) .
Results of RIPA showed that the precursor of the gpl0 and gpl7 subunits [p(gpl0/gpl7)] of gp6/gpl0/gpl7 glycoprotein appeared as early as 6 h p.i., whereas pgpl 1 appeared at 8 h p.i. and gp8 was not detected until 8 to 9 h p.i. (Fig. 2) . The mature forms of gp6, gpl0, gpl7 and gpll were detected about 13 h p.i. (data not shown). No precursor was detected for gp8. When tested by immunofluorescence, gp6/gpl0/gpl7 appeared at 9 h p.i., and gpll/VP24 and gp8 were detected at 10 h p.i. (Fig. 3) . For al! three glycoproteins, only a few cells exhibited fluorescence during the first 2 h of detection, but at 12 h p.i. most of the cells were positive when analysed using MAbs 35, 29 and 114 directed against gp6/gpl0/gpl7, gpl 1/VP24 and gp8, respectively.
To characterize further the temporal control of BHV-4 glycoproteins, the protein synthesis inhibitor cycloheximide (CH) was used to identify alpha proteins. Georgia bovine kidney (GBK) cells were used instead of MDBK cells because of the cytotoxic effect of CH on the latter. GBK cells were treated with CH (100 ~g/ml; Sigma) for various intervals starting from the time of inoculation. Cells were then rinsed twice with MEM and incubated for various times with actinomycin D (AD) (10 ktg/ml; Sigma) in methionine-free MEM containing [35S]methionine (25 ~tCi/ml; Amersham). Incubations were as follows: 6 h CH then 3 h AD, 6 h CH then 5 h AD, 9 h CH then 3 h AD, 9 h CH then 5 h AD, 12 h CH then 5 h AD, 16 h CH then 5 h AD, 16 h CH then 11 h AD, 24 h CH then 16 h AD. Uninfected and infected cells were harvested in RIPA buffer as above.
No glycoprotein was detected by RIPA under these conditions, suggesting that neither glycoprotein was an alpha protein. Moreover no viral protein was identified when infected cell proteins were separated by SDS-PAGE.
Beta proteins were identified by expression in the Treatment with PAA for 15 h p.i. did not inhibit the production of p(gpl0/gpl7) glycoprotein, which indicated that it is expressed during the early phase (Fig. 4) . Immunoprecipitation of infected cell lysates treated for 22 h and 48 h with PAA showed the complete absence of gpl 1, its precursor and gp8, which thus characterized these glycoproteins as strictly controlled gamma proteins. When infected cells were treated for 48 h with PAA, only the precursor form of gp6/gpl0/gpl7 was detected. Moreover, the rate of p(gpl0/gpl7) synthesis was about four times lower in the presence of PAA than in its absence (data not shown). Immunoprecipitation of infected cell lysate treated for 48 h p.i. with PAA and using a polyclonal antiserum showed the presence of two viral bands (132K and 110K), one of which showed the same migration profile as p(gpl0/gpl7) (Fig. 5) . Only MAbs to gp6/gpl0/gpl7 glycoprotein showed positive fluorescence on infected cells treated for 48 h p.i. with PAA and the fluorescence intensity was weaker than in untreated infected cells.
The BHV-4 glycoproteins appeared later after infection than those of BHV-1 (Ludwig & Letchworth, 1987) . BHV-1 is an alphaherpesvirus and BHV-4 was previously classified as a betaherpesvirus on the basis of some of its biological characteristics, such as its morphogenesis and slow growth (Storz et al., 1984) . Moreover, these results are in accordance with those of Augsburger & Metzler (1989) who detected, by immunofluorescence, the first appearance of BHV-4 antigen at 8 h p.i. with MAbs which seemed to be directed against gp6/gpl0/gpl7 glycoprotein. Immunoprecipitation was shown to be more sensitive than immunofluorescence because the first appearance of BHV-4 glycoproteins was detected 2 to 3 h earlier.
It should be pointed out that MAbs may recognize only mature epitopes. The maturation of certain viral epitopes may be delayed in relation to other epitopes, which could artificially delay the time of appearance of the protein detected by RIPA. To avoid this problem, parallel immunoprecipitation procedures were done with a rabbit antiserum, but no difference was observed in the temporal appearance of BHV-4 glycoproteins gp6/gpl0/gpl7, gpll/VP24 and gp8. BHV-4 glycoproteins were synthesized until the cells were lysed; indeed these proteins were detected with the same intensity at 76 h p.i. when c.p.e, was about 30%. Nevertheless the intensity of the gp8 band decreased after 54 h p.i. This protein is secreted into the supernatant of productively infected ceils (J. Dubuisson et al., unpublished results) and could explain the weaker intensity of the gp8 band at the end of the experiment.
Two alpha transcripts have been identified in BHV-4-infected cells (V. Van Santen, personal communication) . We tested various times of exposure to CH and AD but no alpha protein could be detected on polyacrylamide gels. The inability to detect alpha proteins in infected cell cultures treated with CH followed by AD treatment could be due to the weak expression of these proteins. Moreover, such proteins could be masked by cellular Short communication proteins because no inhibition of host cell protein synthesis is observed for BHV-4 (Augsburger & Metzler, 1989) . Immunoprecipitation of infected cell lysate treated for 48 h with PAA using a polyclonal antiserum showed the presence of two viral bands. One of them showed the same migration profile as p(gpl0/gpl7). The other one showed a migration profile different from those of BHV-4 glycopolypeptides described in the literature (Dubuisson et al., 1989b) suggesting that p(gpl0/gpl7) is the only BHV-4 glycoprotein to be expressed during the early phase.
Immunoprecipitations from PAA-treated infected cell lysate show that only the precursor of two components of gp6/gpl0/gpl 7 was detected as late as 48 h p.i. during the early phase. The absence of the mature form of gp6/gp 10/gp 17 could be due to the lack of expression of a BHV-4 protease, involved in glycoprotein maturation, which could be expressed during the late phase. Moreover the synthesis of p(gp 10/gp 17) increased during the late phase, suggesting that the gene for this glycoprotein is regulated as beta-gamma class. In contrast gpl 1/VP24 and gp8 genes seem to be regulated as gamma class.
Therefore, one glycoprotein [p(gpl0/gpl7)] appears during the early stage of infection. This feature has also been described for other herpesviruses (Ludwig & Letchworth, 1987; Sullivan et al., 1989) and provides an antigen which is expressed in the infected cell before the maturation of viral particles. Such cells could be targets for antibody-dependent cell-mediated immunity and cytotoxic T cells. Control of viral infection could therefore be achieved by stimulating these immune responses, which are able to impede the spread of BHV-4 infection from cell to cell and its excretion from infected animals.
